Protara Therapeutics, Inc. Effective Income Tax Rate Reconciliation, Tax Credit, Amount
Protara Therapeutics, Inc. (TARA) reported Effective Income Tax Rate Reconciliation, Tax Credit, Amount of $465.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-20.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationTaxCredits · last filed 2020-03-20
- Protara Therapeutics, Inc. effective income tax rate reconciliation, tax credit, amount for fiscal 2019 was $465.00K, a 68.28% decline from fiscal 2018.
- Protara Therapeutics, Inc. effective income tax rate reconciliation, tax credit, amount for fiscal 2018 was $1.47M, a 73.32% decline from fiscal 2017.
- Protara Therapeutics, Inc. effective income tax rate reconciliation, tax credit, amount for fiscal 2017 was $5.50M, a 13.39% increase from fiscal 2016.
- Protara Therapeutics, Inc. effective income tax rate reconciliation, tax credit, amount for fiscal 2016 was $4.85M, a 14.86% increase from fiscal 2015.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Amount 12 month |
|---|---|
| 2019-12-31 | $465.00K 10-K · filed 2020-03-20 |
| 2018-12-31 | $1.47M 10-K · filed 2020-03-20 |
| 2017-12-31 | $5.50M 10-K · filed 2019-03-13 |
| 2016-12-31 | $4.85M 10-K · filed 2019-03-13 |
| 2015-12-31 | $4.22M 10-K · filed 2018-03-14 |
| 2014-12-31 | $2.18M 10-K · filed 2017-03-16 |
| 2013-12-31 | $7.16M 10-K · filed 2016-03-14 |
| 2012-12-31 | $95.00K 10-K · filed 2015-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |